Zent, C. S., Wang, X. V., Ketterling, R. P., Hanson, C. A., Libby, E. N., Barrientos, J. C., . . . Tallman, M. S. (2016). A Phase II Randomized Trial Comparing Standard and Low Dose Rituximab Combined with Alemtuzumab as Initial Treatment of Progressive Chronic Lymphocytic Leukemia in Older Patients: A Trial of the ECOG-ACRIN Cancer Research Group (E1908). Am J Hematol.
Chicago-стиль цитированияZent, Clive S., et al. "A Phase II Randomized Trial Comparing Standard and Low Dose Rituximab Combined With Alemtuzumab As Initial Treatment of Progressive Chronic Lymphocytic Leukemia in Older Patients: A Trial of the ECOG-ACRIN Cancer Research Group (E1908)." Am J Hematol 2016.
MLA-цитированиеZent, Clive S., et al. "A Phase II Randomized Trial Comparing Standard and Low Dose Rituximab Combined With Alemtuzumab As Initial Treatment of Progressive Chronic Lymphocytic Leukemia in Older Patients: A Trial of the ECOG-ACRIN Cancer Research Group (E1908)." Am J Hematol 2016.